NF2 and neoplasm: When comparing clinical data across the different NF2 groups, we found that age distribution differed significantly, with the lowest median age (15.1 years) in patients with NF2-related schwannomatosis and the highest median age (54.0 years) in patients with NF2 mutations detected in the tumor (Fig. 2f).